These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Proceedings of the Workshop on Intermittent Drug Therapy and Immunological Implications in Antituberculous Treatment with Rifampicin. Oct. 2-3, 1972 Stockholm. Organized by The Department of Thoracic Medicine, Karolinska Sjukhuset. Scand J Respir Dis Suppl; 1973; 84():1-193. PubMed ID: 4593267 [No Abstract] [Full Text] [Related]
5. [Daily and intermittent regimens using ethambutol and rifampicin in the treatment of unresponsive cases. (Evaluation after 1 year.) II. Side effects]. Girling DJ Bull Int Union Tuberc; 1974; 49(1):451-5. PubMed ID: 4619567 [No Abstract] [Full Text] [Related]
6. Side effects during intermittent rifampicin and ethambutol treatment. A preliminary report. Guerra Sanz FJ Scand J Respir Dis Suppl; 1973; 84():160-5. PubMed ID: 4522071 [No Abstract] [Full Text] [Related]
7. Clinical aspects of side effects on intermittent rifampicin regimen. Zierski M Scand J Respir Dis Suppl; 1973; 84():166-73. PubMed ID: 4522072 [No Abstract] [Full Text] [Related]
8. Side effects observed during intermittent rifampicin therapy. Stradling P Scand J Respir Dis Suppl; 1973; 84():129-31. PubMed ID: 4522066 [No Abstract] [Full Text] [Related]
9. Therapeutic effects and side effects of rifampicin administered daily or twice-weekly. Gomi J; Aoyagi T Scand J Respir Dis Suppl; 1973; 84():145-52. PubMed ID: 4522070 [No Abstract] [Full Text] [Related]
10. Preliminary results of a controlled therapeutic trail administering INH-RMP once-weekly, after--or without--an initial period of continuous treatment. Eule H; Kärnbach E; Kaluza P; Herrmann H Scand J Respir Dis Suppl; 1973; 84():153-9. PubMed ID: 4593264 [No Abstract] [Full Text] [Related]